Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Benign recurrent intrahepatic cholestasis.

Velimir A Luketic1, Mitchell L Shiffman

  • 1Hepatology Section, Virginia Commonwealth University Health System, West Hospital, 14th Floor, 1200 East Broad Street, Richmond, VA 23219, USA.

Clinics in Liver Disease
|April 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of belapectin for the prevention of esophageal varices in patients with MASH cirrhosis: The randomized, placebo-controlled NAVIGATE trial.

Hepatology (Baltimore, Md.)·2026
Same author

Prognostic Utility of Systemic Inflammatory Response Syndrome (SIRS) Criteria in Acute Alcohol-Associated Hepatitis.

Digestive diseases and sciences·2026
Same author

Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial.

Journal of hepatology·2025
Same author

Navigating Hepatocellular Carcinoma.

Clinics in liver disease·2024
Same author

Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.

The New England journal of medicine·2023
Same author

Autoimmune Hepatitis: Epidemiology, Subtypes, and Presentation.

Clinics in liver disease·2023

Benign recurrent intrahepatic cholestasis is a rare genetic liver disorder causing intense itching and high bilirubin levels. Caused by ATP8B1 gene mutations, it is not progressive and resolves spontaneously.

Area of Science:

  • Hepatology
  • Genetics
  • Rare Diseases

Background:

  • Benign recurrent intrahepatic cholestasis (BRIC) is a rare, inherited liver disorder.
  • Characterized by recurrent episodes of severe itching (pruritus) and jaundice.
  • Episodes involve elevated serum alkaline phosphatase and bilirubin, with normal gamma-glutamyl transferase.

Purpose of the Study:

  • To summarize the key features of benign recurrent intrahepatic cholestasis.
  • To highlight the genetic basis and protein involvement in the disorder.
  • To outline current therapeutic approaches.

Main Methods:

  • Review of clinical and genetic studies on BRIC.
  • Analysis of the role of the ATP8B1 gene and FIC1 protein.
  • Description of supportive care strategies.

Related Experiment Videos

Main Results:

  • BRIC is an autosomal recessive disorder linked to mutations in the ATP8B1 gene.
  • The FIC1 protein, encoded by ATP8B1, is crucial for bile acid secretion and membrane function.
  • Episodes are self-limiting, lasting weeks to months, with patients asymptomatic between attacks.
  • The condition is non-progressive and not fatal.

Conclusions:

  • Benign recurrent intrahepatic cholestasis is a distinct genetic cholestatic liver disease.
  • Mutations in ATP8B1/FIC1 are the underlying cause, affecting bile transport.
  • Management focuses on symptomatic relief during cholestatic episodes.